| Full text | |
| Author(s): |
Total Authors: 3
|
| Affiliation: | [1] Univ Sao Paulo, Biomed Sci Inst, Pharmacol Dept, BR-05508000 Sao Paulo, SP - Brazil
[2] Weizmann Inst Sci, Dept Biol Regulat, IL-7610001 Rehovot - Israel
Total Affiliations: 2
|
| Document type: | Review article |
| Source: | BIOMOLECULES; v. 10, n. 9 SEP 2020. |
| Web of Science Citations: | 2 |
| Abstract | |
Thimet oligopeptidase (EC 3.4.24.15; EP24.15, THOP1) is a metallopeptidase ubiquitously distributed in mammalian tissues. Beyond its previously well characterized role in major histocompatibility class I (MHC-I) antigen presentation, the recent characterization of the THOP1 C57BL6/N null mice (THOP1(-/-)) phenotype suggests new key functions for THOP1 in hyperlipidic diet-induced obesity, insulin resistance and non-alcoholic liver steatosis. Distinctive levels of specific intracellular peptides (InPeps), genes and microRNAs were observed when comparing wild type C57BL6/N to THOP1(-/-)fed either standard or hyperlipidic diets. A possible novel mechanism of action was suggested for InPeps processed by THOP1, which could be modulating protein-protein interactions and microRNA processing, thus affecting the phenotype. Together, research into the biochemical and biomedical significance of THOP1 suggests that degradation by the proteasome is a step in the processing of various proteins, not merely for ending their existence. This allows many functional peptides to be generated by proteasomal degradation in order to, for example, control mRNA translation and the formation of protein complexes. (AU) | |
| FAPESP's process: | 16/04000-3 - Pharmacology of oligopeptidases and intracellular peptides |
| Grantee: | Emer Suavinho Ferro |
| Support Opportunities: | Research Projects - Thematic Grants |